About Xbiome
Xbiome is a company based in Shenzhen (China) founded in 2017. Xbiome has raised $107.5 million across 5 funding rounds from investors including Primavera Capital Group, Gaorong Capital and Legend Capital. Xbiome operates in a competitive market with competitors including DNAnexus, Helix, Benchling, Cytel and Genuity Science, among others.
- Headquarter Shenzhen, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$107.5 M (USD)
in 5 rounds
-
Latest Funding Round
$100 M (USD), Series B
Dec 22, 2021
-
Investors
Primavera Capital Group
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Xbiome
Unlock access to complete
Funding Insights of Xbiome
Xbiome has successfully raised a total of $107.5M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $100 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Xbiome
Xbiome has secured backing from 10 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Primavera Capital Group, Gaorong Capital and Legend Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and growth-stage TMT startups are funded in China.
|
Locked | Locked | Locked | |
|
Venture Capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Tech investments are made stage-agnostically in China and the US.
|
Locked | Locked | Locked |
Investor details for Xbiome
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xbiome
Investment portfolio details for Xbiome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xbiome
Detailed financials for Xbiome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xbiome Comparisons
Peer comparison for Xbiome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xbiome
Xbiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Helix, Benchling, Cytel and Genuity Science, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
Detailed competitors of Xbiome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xbiome
Complete news archive for Xbiome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xbiome
Xbiome was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Xbiome is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Xbiome is a funded company, having raised a total of $107.5M across 5 funding rounds to date.
Xbiome was founded in 2017 in Shenzhen, China, within the biotechnology sector. An AI-enabled bioinformatics platform is utilized by the company to identify drugs based on the intestinal microbiome. Fecal microbiota transplantation (FMT) technology is employed for drug development targeting multiple diseases. Microbiota from healthy donors stool is extracted through established methods and transplanted into patients for therapeutic purposes across various conditions.
Xbiome has 10 investors. Key investors include Primavera Capital Group, Gaorong Capital, Legend Capital, Sky9 Capital, and 5Y Capital.